Free Trial
OTCMKTS:RNVAD

Rennova Health (RNVAD) Stock Price, News & Analysis

Rennova Health logo

About Rennova Health Stock (OTCMKTS:RNVAD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6.98 million shs
Average Volume
1.28 million shs
Market Capitalization
$318.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNVAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rennova Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RNVAD Stock News Headlines

The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel
See More Headlines

RNVAD Stock Analysis - Frequently Asked Questions

Rennova Health shares reverse split on the morning of Wednesday, March 16th 2022.The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Shares of RNVAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
General Medical & Surgical Hospitals
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:RNVAD
CIK
931059
Employees
60
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
($234.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.34 million
Net Margins
N/A
Pretax Margin
-476.63%
Return on Equity
N/A
Return on Assets
-77.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.05
Quick Ratio
0.05

Sales & Book Value

Annual Sales
$7.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
44,276,552,000
Free Float
19,694,210,000
Market Cap
$318.79 million
Optionable
Not Optionable
Beta
18.08

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:RNVAD) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners